 |
|
Pancreatoduodenectomy for Pancreatic Adenocarcinoma
Triumph, Triumphalism, or Transition?
Edward L. Bradley III, MD
Sarasota, Fla
Arch Surg. 2002;137:771-773.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
AS SURGEONS, we can be justifiably proud of the truly remarkable reductions in operative mortality rates following pancreatoduodenectomy for pancreatic adenocarcinoma that have been achieved within the past decade. Thirty-day mortality rates of 5%, or even less, are commonly reported today.1-6 Few would deny that these rates represent a technical triumph when compared with the 20% to 30% operative mortality rates that were experienced only a generation ago. The establishment of high-volume pancreatic surgical centers has been an important part of this success.7-10 Credit for this dramatic decrease in surgical mortality cannot be claimed solely by the surgical profession, however, as other significant advances, such as improvements in perioperative care and imaging techniques, occurred during this same period. Nevertheless, it can no longer be persuasively argued, as it was in the 1970s by Crile11 and others,12 that because the operative mortality for pancreatoduodenectomy exceeded the . . . [Full Text of this Article]
RELATED ARTICLES
This Month in Archives of Surgery
Arch Surg. 2002;137(7):769.
FULL TEXT
Pancreatoduodenectomy for Pancreatic Adenocarcinoma—Invited Critique
Michael Trede
Arch Surg. 2002;137(7):773.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Improving the Results of Pancreatoduodenectomy
Huguier and Bradley III
Arch Surg 2002;137:1447-1447.
FULL TEXT
|
